Since there are many reports showing that p-FAK proteins were overexpressed in other types of malignant cancers besides OSCC and osteosarcoma, it is expected that the combinational treatment method of NCP and p-FAK/GNP can be applied to various types of cancers. This evidence concerns the gene PTK2 and osteosarcoma.